Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA — Stella

Home/Stomach Cancer Stage IV/

View on ClinicalTrials.gov

Recruiting

Back to Stomach Cancer Stage IV trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

UCLA, Santa Monica, California

Massachusetts General Hospital, Boston, Massachusetts

Key details

Phase

Safety & dosing

Sponsor

Massachusetts General Hospital

Collaborators

Summit Therapeutics

Enrollment target

~40 participants

Started

October 2025

Primary completion

December 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.